BEX1 interacts with RUNX3 to inhibit RUNX3-mediated β-catenin transcriptional repression, activating the Wnt/β-catenin signaling pathway and maintaining CSC-HCC stemness. Here, RUNX3 is linked to hepatocellular carcinoma.